Page 43 - GPD-1-2

Gene & Protein in Disease RUNX1 gene in female-related cancers

47. Lin TC, 2022, RUNX1 and cancer. Biochim Biophys Acta Rev https://doi.org/10.1038/s41598-018-24969-w
Cancer, 1877(3): 188715.
59. Ramsey J, Butnor K, Peng Z, et al., 2018, Loss of RUNX1
https://doi.org/10.1016/j.bbcan.2022.188715 is associated with aggressive lung adenocarcinomas. J Cell
48. Na Y, Huang G, Wu J, 2020, The Role of RUNX1 in NF1- Physiol, 233(4): 3487–3497.
related tumors and blood disorders. Mol Cells, 43(2): https://doi.org/10.1002/jcp.26201
153–159.
60. Bogoch Y, Friedlander-Malik G, Lupu L, et al., 2017,
https://doi.org/10.14348/molcells.2019.0295 Augmented expression of RUNX1 deregulates the global
49. Mercado-Matos J, Matthew-Onabanjo AN, Shaw LM, 2017, gene expression of U87 glioblastoma multiforme cells
RUNX1 and breast cancer. Oncotarget, 8(23): 36934–36935. and inhibits tumor growth in mice. Tumour Biol, 39(4):
1010428317698357.
https://doi.org/10.18632/oncotarget.17249
https://doi.org/10.1177/1010428317698357
50. Fernando PG, Morolli B, Storlazzi CT, et al., 2003,
Identification of RUNX1/AML1 as a classical tumor 61. Liu C, Xu D, Xue B, et al., 2020, Upregulation of RUNX1
suppressor gene. Oncogene, 22(4): 538–547. suppresses proliferation and migration through repressing
VEGFA expression in hepatocellular carcinoma. Pathol
https://doi.org/10.1038/sj.onc.1206141 Oncol Res, 26(2): 1301–1311.
51. Ferrari N, Mohammed ZM, Nixon C, et al., 2014, Expression https://doi.org/10.1007/s12253-019-00694-1
of RUNX1 correlates with poor patient prognosis in triple
negative breast cancer. PLoS One, 9(6): e100759. 62. Sun L, Wang L, Chen T, et al., 2020, LncRNA RUNX1-IT1
which is downregulated by hypoxia-driven histone deacetylase
https://doi.org/10.1371/journal.pone.0100759 3 represses proliferation and cancer stem-like properties in
52. De Braekeleer E, Férec C, De Braekeleer M, 2009, RUNX1 hepatocellular carcinoma cells. Cell Death Dis, 11: 95.
translocations in malignant hemopathies. Anticancer Res, https://doi.org/10.1038/s41419-020-2274-x
29(4): 1031–1037.
63. Szmajda-Krygier D, Krygier A, Jamroziak K, et al., 2022,
53. Walker LC, Stevens J, Campbell H, et al., 2002, A novel RUNX1 and RUNX3 genes expression level in adult acute
inherited mutation of the transcription factor RUNX1 lymphoblastic leukemia-a case control study. Curr Issues
causes thrombocytopenia and may predispose to acute Mol Biol, 44: 3455–3464.
myeloidleukaemia. Br J Haematol, 117: 878–881.
https://doi.org/10.3390/cimb44080238
https://doi.org/10.1046/j.1365-2141.2002.03512.x
64. Sanda T, 2017, RUNX1 in T-ALL: Tumor suppressive or
54. Tuo Z, Zhang Y, Wang X, et al., 2022, RUNX1 is a promising oncogenic? Blood, 130(15): 1686–1688.
prognostic biomarker and related to immune infiltrates
of cancer-associated fibroblasts in human cancers. BMC https://doi.org/10.1182/blood-2017-08-802181
Cancer, 22: 523. 65. Kurokawa M, Tanaka T, Tanaka K, et al., 1996, Overexpression
https://doi.org/10.1186/s12885-022-09632-y of the AML1 proto-oncoprotein in NIH3T3 cells leads to
neoplastic transformation depending on the DNA-binding
55. Liu K, Hu H, Jiang H, et al., 2021, RUNX1 promotes MAPK and transactivational potencies. Oncogene, 12: 883–892.
signaling to increase tumor progression and metastasis via
OPN in head and neck cancer. Carcinogenesis, 42(3): 414–422. 66. Aird WC, 2011, Endothelial cell heterogeneity. Cold Spring
Harb Perspect Med, 2(1): a006429.
https://doi.org/10.1093/carcin/bgaa116
https://doi.org/10.1101/cshperspect.a006429
56. Otálora-Otálora BA, Henríquez B, López-Kleine L, et al.,
2019, RUNX family: Oncogenes or tumor suppressors 67. Sroczynska P, Lancrin C, Kouskoff V, et al., 2009, The
(Review). Oncol Rep, 42(1): 3–19. differential activities of RUNX1 promoters define milestones
during embryonic hematopoiesis. Blood, 114(26): 5279–5289.
https://doi.org/10.3892/or.2019.7149
https://doi.org/10.1182/blood-2009-05-222307
57. Gaidzik VI, Teleanu V, Papaemmanuil E, et al., 2016, RUNX1
mutations in acute myeloid leukemia are associated with 68. Chou BK, Bai H, Gao Y, et al., 2015, The roles of RUNX1
distinct clinico-pathologic and genetic features. Leukemia, in human hematopoiesis and megakaryopoiesis revealed
30: 2160–2168. by genome-targeted human iPSCs and an improved
hematopoietic differentiation model. Blood, 126: 1167.
https://doi.org/10.1038/leu.2016.126
https://doi.org/10.1182/blood.V126.23.1167.1167
58. Mitsuda Y, Morita K, Kashiwazaki G, et al., 2018, RUNX1
positively regulates the ErbB2/HER2 signaling pathway 69. Ichikawa M, Yoshimi A, Nakagawa M, et al., 2013, A role
through modulating SOS1 expression in gastric cancer cells. for RUNX1 in hematopoiesis and myeloid leukemia. Int J
Sci Rep, 8(1): 6423. Hematol, 97: 726–734.

Volume 1 Issue 2 (2022) 14 https://doi.org/10.36922/gpd.v1i2.147